Notes
HMG-CoA reductase inhibitors
National Health Service
Reference
NICE. NICE draft guidance recommends new drugs for cholesterol disorder. Media Release : 5 May 2016. Available from: URL: http://www.nice.org.uk
Rights and permissions
About this article
Cite this article
Alirocumab and evolocumab recommended by NICE. PharmacoEcon Outcomes News 753, 33 (2016). https://doi.org/10.1007/s40274-016-3066-5
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-016-3066-5